Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.5.3 to v3.5.4. This reflects a minor update to the page's metadata.
    Difference
    0.1%
    Check dated 2026-05-17T09:58:26.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page’s release/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site or system revision rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-04-25T18:47:52.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page footer.
    Difference
    0.1%
    Check dated 2026-04-18T13:39:33.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page shows new study record date entries for 2026-04-02, 2026-03-31, and 2026-03. Older dates 2026-02-10, 2026-01-29, and 2026-01 have been removed.
    Difference
    0.2%
    Check dated 2026-04-04T06:13:18.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T01:20:52.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 removed, indicating a minor metadata update to the page.
    Difference
    0.1%
    Check dated 2026-03-06T18:44:20.000Z thumbnail image

Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.